Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mohsen Bannazadeh

Surgery Royal Oak, MI Medical Doctor

NPI 1134354988 CMS profile 1107557

3601 W 13 Mile Rd, Ste 106C, Royal Oak, MI 48073

Open in the dashboard

General payments

$70,502

460 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mohsen Bannazadeh of Royal Oak, MI is reported in the CMS Open Payments database as having received $70,502 across 460 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16,353 53
2024 General $8,083 51
2023 General $3,265 45
2022 General $14,681 85
2021 General $22,090 102
2020 General $1,418 46
2019 General $4,612 78

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mohsen Bannazadeh
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Mohsen Bannazadeh were reported at $16,353. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Mohsen Bannazadeh Surgery median Middle half National median
2019 $4,612 $253 $82–$1,521 $163
2020 $1,418 $131 $40–$706 $114
2021 $22,090 $168 $50–$904 $132
2022 $14,681 $224 $76–$1,218 $149
2023 $3,265 $253 $82–$1,255 $160
2024 $8,083 $279 $90–$1,381 $164
2025 $16,353 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Terumo Medical Corporation $23,884 40 payments
  2. Medtronic, Inc. $23,849 109 payments
  3. Cook Incorporated $3,600 2 payments
  4. Penumbra, Inc. $3,515 19 payments
  5. W. L. Gore & Associates, Inc. $3,218 34 payments
  6. Bolton Medical Inc $3,051 25 payments
  7. Tactile Systems Technology Inc $2,524 98 payments
  8. Cook Medical LLC $2,210 55 payments
  9. Silk Road Medical, Inc. $1,220 15 payments
  10. Medtronic Vascular, Inc. $932 14 payments
  11. Other $2,498 49 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $22,000 13 payments
  2. Food and Beverage $20,934 406 payments
  3. Travel and Lodging $15,837 32 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,200 6 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,500 1 payment
  6. Gift $24 1 payment
  7. Education $6 1 payment
Products named General payments · program years 2019–2025
  1. ENDURANT IIS $19,361 63 payments
  2. GLIDESHEATH SLENDER $9,583 16 payments
  3. NAVICROSS $8,627 7 payments
  4. GLIDEWIRE $8,627 7 payments
  5. Azur CX Detachable $8,549 14 payments
  6. HydroPearl $8,227 6 payments
  7. RUBY Coil $2,614 6 payments
  8. ZENITH ALPHA $2,518 10 payments
  9. Flexitouch Plus $1,891 41 payments
  10. Cook Medical IAA $1,500 1 payment
  11. Other $22,929 488 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 93 billing codes

Paid by Medicare

$118,728

Medicare's payments for the services billed

Medicare patients

205

Average age 76

Services billed

718

104 women, 101 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 71%
Diabetes 61%
Arthritis 60%
Heart failure 50%
Chronic kidney disease 47%
Atrial fibrillation 34%
COPD 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

460 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record